Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

ImmunoCellular Therapeutics Ltd Company Profile (NASDAQ:IMUC)

Consensus Ratings for ImmunoCellular Therapeutics Ltd (NASDAQ:IMUC) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.00 (523.57% upside)

Analysts' Ratings History for ImmunoCellular Therapeutics Ltd (NASDAQ:IMUC)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/13/2015Roth CapitalInitiated CoverageBuy$3.00ViewTweet This Rating  Share This Rating on StockTwits
3/10/2015Maxim GroupLower Price TargetBuy$4.00 -> $3.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/20/2013 forward)